Jefferies analyst Glen Santangelo reiterated a Buy rating and $51.00 price target on Collegium Pharmaceutical (NASDAQ: COLL)The analyst commented, "COLL ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments